For mine , with prr stating that they were looking to expand in the second quarter of next year into other cancer types ,and mentioning also that they were always looking to minimise expenditure,they also stated they were in talks with large pharmas and bios,,you may be able to presume that they could possibly be working on some kind of j.v deal ,and may be looking to complete negotiations in 1 st quarter next year,or there cost constraints don't add up..just a thought ,,any thoughts on how else they would expect to expand there research ??
next cyclic peak on its way, page-16
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 85852 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 75389 | 4 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |